Revvity
RVTY
Approvals, recalls and adverse events. Includes companies and brands it has bought. Official US government data, updated October 2026.
29
New devices cleared or approved
29
New devices cleared or approved
510(k) clearances
25
De Novo: 3
PMA approvals
1
12 supplements
Recalled products
58
0 class I
Adverse event reports
92
1 deaths reported
Questions and answers
How many recalls does Revvity have?
Revvity has 58 recalled medical device products in 34 recall actions in the records, 0 of them class I (the most serious kind). The newest recall started on Jan 10, 2019. In 2018 it had 1 recalled products.
How many medical devices has Revvity had cleared or approved?
25 510(k) clearances, 3 De Novo grants and 1 original PMA approvals for high-risk devices, plus 12 PMA supplements (changes to approved devices). The newest decision was on Sep 30, 2026.
How many adverse event reports name Revvity devices?
92 reports in total: 1 deaths, - injuries and 86 malfunctions were reported. 5 reports were received in 2021. A report alone does not show that the device caused the problem.
Clearances, approvals, recalls and reports by year
Clearances and approvals
Recalled products
Adverse event reports received
Newest clearances and approvals
| Device | Pathway | Decision |
|---|---|---|
| Eonis SMA kitK262893 | 510(k) clearance | Sep 30, 2026 |
| Eonis SCID-SMA kitK203035 | 510(k) clearance | Nov 9, 2022 |
| Eonis SCID-SMA KitDEN200044 | De Novo grant | Nov 9, 2022 |
| NeoBase 2 Non-derivatized MSMS KitK193103 | 510(k) clearance | Feb 7, 2020 |
| GSP Neonatal Creatine Kinase - MM kitDEN180056 | De Novo grant | Dec 12, 2019 |
| GSP Neonatal Total Galactose kitK190335 | 510(k) clearance | Nov 6, 2019 |
| NeoLSD MSMS KitK190266 | 510(k) clearance | May 3, 2019 |
| NeoBase 2 Non-derivatized MSMS KitK173568 | 510(k) clearance | Sep 4, 2018 |
| NeoLSD MSMS kitK173829 | 510(k) clearance | Jul 18, 2018 |
| PerkinElmer XRpad2 4336 HWC-M Flat Panel DetectorK161966 | 510(k) clearance | Sep 8, 2016 |
| PerkinElmer, XRpad2 3025 HWC-M Flat Panel DetectorK161942 | 510(k) clearance | Sep 1, 2016 |
| PerkinElmer, XRpad 4343 F MED Flat Panel DetectorK142698 | 510(k) clearance | Oct 23, 2014 |
| PERKINELMER, XRPAD 4336 MED FLAT PANEL DETECTORK140551 | 510(k) clearance | Aug 1, 2014 |
| GSP NEONATAL TOTAL GALACTOSE KITK133652 | 510(k) clearance | Apr 28, 2014 |
| PERKINELMER 226 SAMPLE COLLECTION DEVICESK121864 | 510(k) clearance | Mar 12, 2013 |
Newest recalls
| Product | Class | Started |
|---|---|---|
| AutoDELFIA hCG Kit, In Vitro Diagnostic for the determination of human gonadotropin (hCG) | Class II | Jan 10, 2019 |
| AutoDELFIA hCG Kit, In Vitro Diagnostic for the determination of human gonadotropin (hCG) | Class II | Jan 10, 2019 |
| DELFIA hCG Kit, In Vitro Diagnostic for the determination of human gonadotropin (hCG) Prod | Class II | Jan 10, 2019 |
| PerkinElmer QSight 210 MD Mass Spectrometer Simplicity 3Q MD v1.0 with Hot Fix 2 Software | Class II | Sep 24, 2018 |
| PerkinElmer 226 Sample Collection Device | Class III | Dec 19, 2017 |
| Specimen Gate Screening Center, Part Number 5002-0500, All software versions from 1.0 to 1 | Class II | Nov 17, 2017 |
| NeoBase Succinylacetone Assay Solution, Product Number: 3042-0020; Affected UDI Numbers: ( | Class II | Nov 2, 2017 |
| AutoDELFIA Neonatal immunoreactive trypsin(ogen) (IRT) kit, intended for the quantitative | Class III | Sep 25, 2017 |
| JANUS & JANUS G3 Automated Workstation is an automated programmable liquid handling instru | Class III | Aug 2, 2017 |
| PerkinElmer 226 Sample Collection Device The PerkinElmer 226 Sample Collection Device is i | Class III | May 31, 2017 |
Devices with the most adverse event reports
By product code, all years
Product codes
All device makers and procedures · RVTY stock page
Official US government data on medical device marketing decisions, recalls (one row per recalled product) and adverse event reports. Company names in the records are linked to RVTY with a reviewed list that includes the companies it has bought. Adverse event reports come from makers, hospitals, doctors and patients; a report alone does not prove that a device caused the problem.